A team at Microsoft Research has figured out a way to share encrypted information stored in the cloud without compromising security. The example the outfit gives is as follows: ” Machine learning algorithms may examine our genomes to determine our susceptibility to maladies such as heart disease and cancer. Between now and then, computer scientists need to train the algorithms on genetic data, bundles of which are increasingly stored encrypted and secure in the cloud along with financial records, vacation photos and other bits and bytes of digitized information.” Given the nature of encryption , though, only the owners of said data can access it. Good for security, but bad for researchers. The methodology proposed by the team uses multiparty computation, where results are shared, but no one involved learns any of the specifics about the data contained in the encrypted file. “We require that none of the parties involved learns anything beyond what they already know and what is revealed by the function, even when the parties (except the cloud) are active malicious, ” the research brief says. So, essentially, it’s a lot like having an impartial pal know the number of books in two friends’ collections. From there, the third party would tell each friend who’s bookshelf has more on it, without saying exactly how many books are on either shelf. Encryption computations are all performed within the cloud as well, and the scientists involved say that the computations themselves are encrypted. The servers don’t even know what they’re processing. “Set up this way, the data exchange is secure provided that the cloud itself follows the rules and nothing more, ” the post says. The end result could apparently make it easier for scientists to preview data for experiments without buying it. What’s more, it’d they’d only have to make a costly purchase once they know the data is worthwhile for their studies. Source: Microsoft Research Blog (1) , (2)
Read this article:
Microsoft figured out how cloud servers can swap encrypted data
An anonymous reader writes: A new study by researchers at Ohio State University found that dramatically increasing the amount of saturated fat in a person’s diet did not increase the amount of saturated fat found in their blood. Professor Jeff Volek, the study’s senior author, said it “challenges the conventional wisdom that has demonized saturated fat and extends our knowledge of why dietary saturated fat doesn’t correlate with disease.” The study also showed that increasing carbohydrates in the diet led to an increase in a particular fatty acid previous studies have linked to heart disease. Volek continued, “People believe ‘you are what you eat, ‘ but in reality, you are what you save from what you eat. The point is you don’t necessarily save the saturated fat that you eat. And the primary regulator of what you save in terms of fat is the carbohydrate in your diet. Since more than half of Americans show some signs of carb intolerance, it makes more sense to focus on carb restriction than fat restriction.” Read more of this story at Slashdot. 
multicsfan writes Researchers have found that an injection of protein FGF1 stops weight induced diabetes in mice, with no apparent side effects. However, the cure only lasts 2 days at a time. Future research and human trials are needed to better understand and create a working drug. From the story: “The team found that sustained treatment with the protein doesn’t merely keep blood sugar under control, but also reverses insulin insensitivity, the underlying physiological cause of diabetes. Equally exciting, the newly developed treatment doesn’t result in side effects common to most current diabetes treatments.” Read more of this story at Slashdot. 
An anonymous reader writes A cure for Type 1 diabetes is still far from sight, but new research suggests an artificial “bionic pancreas” holds promise for making it much more easily manageable. From the article: “Currently about one-third of people with Type 1 diabetes rely on insulin pumps to regulate blood sugar. They eliminate the need for injections and can be programmed to mimic the natural release of insulin by dispensing small doses regularly. But these pumps do not automatically adjust to the patient’s variable insulin needs, and they do not dispense glucagon. The new device, described in a report in The New England Journal of Medicine, dispenses both hormones, and it does so with little intervention from the patient.” Read more of this story at Slashdot. 
